https://www.selleckchem.com/pr....oducts/valproic-acid
1 ± 5.2 kg/m preoperatively to 30.1 ± 4.8 kg/m at 1 year and 31.5 ± 4.9 kg/m at 3 years (P 0.001). There was significant reduction in IPSS total symptom score, quality of life score, frequency score, and nocturia score (P 0.05). The prevalence of moderate to severe LUTS reduced from 35.0% (29.4% moderate; 5.6% severe) preoperatively to 21.8% (19.3% moderate; 2.5% severe) at 1 year and 30.4% (24.6% moderate; 5.8% severe) at 3 years (P 0.001). LUTS improvement was significantly associated with body fat percentage redu
Like
Comment
Share
